Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial
Titel:
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial
Auteur:
Maréchal, Céline Lal, Himal Poder, Airi Ferguson, Murdo Enweonye, Igwebuike Heineman, Thomas C Hervé, Caroline Rheault, Paul Talli, Jaak Wauters, Dominique Oostvogels, Lidia